Viatris Inc

NASDAQ:VTRSUnited States

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as the Company’s ARV franchise. Its portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas, including key brands and generics, including complex products. It operates around 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Contact Information

Headquarters

1000 Mylan BoulevardCANONSBURG, PA, United States 15317

Phone

724-514-1800

Fax

302-655-5049

Executives

Chairman Emeritus of the Board

Robert Coury

Chief Executive Officer, Director

Scott Smith

Lead Independent Vice Chairman of the Board

Mark Parrish

Chief Financial Officer

Theodora Mistras

President, Japan, Australia and New Zealand

Andrew Cuneo